Pharmaceutical Services News - Latest Updates & Headlines
US tariffs will have minimal impact on Indian pharma service companies like CDMOs: Report
New Delhi, March 10: Indian pharma companies like CDMOs (Contract Development and Manufacturing Organizations) will not see major disruptions from the proposed US tariffs of 10-25 per cent, according to a report by B&K Securities.